Pomalidomide Capsules

Pomalidomide Capsules

Categories : Oncology

Product Packaging : 21 in HDPE

Product Composition : 1mg, 2mg, 3mg, 4mg

Send Message

Pomalidomide Capsules are immunomodulatory medications used in the treatment of multiple myeloma and certain hematological malignancies. The medicine works by modulating immune system activity, inhibiting abnormal cell growth, and reducing the formation of blood vessels that support tumor development. Genliva Wellness LLP is a trusted Pomalidomide Capsules Manufacturer in India offering high-quality oncology and hematology formulations for domestic and international pharmaceutical markets.

This oral formulation is commonly prescribed for patients with relapsed or refractory multiple myeloma. As a reliable Pomalidomide Capsules Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Pomalidomide is an important therapeutic option in the management of advanced multiple myeloma and helps improve disease control in patients who have received prior treatments.

Pomalidomide Capsules are formulated to provide immunomodulatory and antineoplastic activity in hematological disorders.

  • Contains Pomalidomide as the active ingredient
  • Immunomodulatory anticancer agent
  • Modulates immune system responses
  • Inhibits abnormal plasma cell growth
  • Reduces tumor-supporting blood vessel formation
  • Oral capsule formulation

Pomalidomide Capsules are used in the treatment and management of hematological malignancies.

  • Multiple myeloma
  • Relapsed multiple myeloma
  • Refractory multiple myeloma
  • Plasma cell disorders
  • Advanced hematological malignancies
  • Combination therapy for myeloma treatment

Pomalidomide Capsules provide effective therapeutic support in the management of blood-related cancers.

  • Helps suppress abnormal plasma cell proliferation
  • Supports immune-mediated anticancer activity
  • Assists in controlling disease progression
  • Effective in previously treated myeloma cases
  • Supports long-term disease management
  • Contributes to improved clinical outcomes

whatsapp-app